Antiepileptic drug treatment: Outcomes and adherence

被引:56
作者
Garnett, WR [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 08期
关键词
D O I
10.1592/phco.20.12.191S.35250
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The goal in treating patients with epilepsy is a cost-effective approach to the elimination of seizures or a reduction in their number and frequency while avoiding drug interactions and side effects, so as to achieve the best possible quality of life. Among the desirable outcomes are an enhanced understanding of epilepsy by patients, caregivers, and society, and a lessening of the psychosocial risks of this disease. Patients fail to achieve their goals and outcomes when they fail to adhere to the drug regimen or when a less-than-adequate drug regimen is prescribed. To help improve adherence, once- or twice-daily formulations should be used. New antiepileptic drugs (AEDs) increase the possibility of effective treatment for a patient who initially fails therapy. Working together, patients and clinicians can maximize the effectiveness of AED therapy and the potential for achieving desired goals and outcomes.
引用
收藏
页码:191S / 199S
页数:9
相关论文
共 70 条
[1]   Commission on outcome measurement in epilepsy, 1994-1997: Final report [J].
Baker, GA ;
Camfield, C ;
Camfield, P ;
Cramer, JA ;
Elger, CE ;
Johnson, AL ;
da Silva, AM ;
Meinardi, H ;
Munari, C ;
Perucca, E ;
Thorbecke, R .
EPILEPSIA, 1998, 39 (02) :213-231
[2]   SOCIOBEHAVIORAL DETERMINANTS OF COMPLIANCE WITH HEALTH AND MEDICAL CARE RECOMMENDATIONS [J].
BECKER, MH ;
MAIMAN, LA .
MEDICAL CARE, 1975, 13 (01) :10-24
[3]   COST OF EPILEPSY IN THE UNITED-STATES - A MODEL-BASED ON INCIDENCE AND PROGNOSIS [J].
BEGLEY, CE ;
ANNEGERS, JF ;
LAIRSON, DR ;
REYNOLDS, TF ;
HAUSER, WA .
EPILEPSIA, 1994, 35 (06) :1230-1243
[4]   Drug utilization 90% -: a simple method for assessing the quality of drug prescribing [J].
Bergman, U ;
Popa, C ;
Tomson, Y ;
Wettermark, B ;
Einarson, TR ;
Åberg, H ;
Sjöqvist, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (02) :113-118
[5]   Factors influencing compliance with antiepileptic drug regimes [J].
Buck, D ;
Jacoby, A ;
Baker, GA ;
Chadwick, DW .
SEIZURE, 1997, 6 (02) :87-93
[6]   ACUTE AND CHRONIC TOXICITY OF ANTIEPILEPTIC MEDICATIONS - A SELECTIVE REVIEW [J].
CAMFIELD, P ;
CAMFIELD, C .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 21 (03) :S7-S11
[7]   EFFECT OF ANTACIDS ON PHENYTOIN BIOAVAILABILITY [J].
CARTER, BL ;
GARNETT, WR ;
PELLOCK, JM ;
STRATTON, MA ;
HOWELL, JR .
THERAPEUTIC DRUG MONITORING, 1981, 3 (04) :333-340
[8]   EPILEPSY [J].
CHADWICK, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (03) :264-277
[9]  
Cimmino Angela, 1994, Epilepsia, V35, P58
[10]  
Collins Rebeccah J., 1998, Epilepsia, V39, P236